European Private Equity Secondaries: Macro Trends, Interest Rates and Investment Opportunities in 2026

Private Equity Insights

European Private Equity Secondaries: Macro Trends, Interest Rates and Investment Opportunities in 2026

The macro consensus has shifted sharply in the past four weeks. US 10-year Treasury yields have climbed back above 4.60%, 30-year yields have breached 5%, and traders who were pricing in Federal Reserve rate cuts as recently as April are now assigning meaningful probability to a hike before year-end. Across the Atlantic, the European Central Bank has held rates on hold, and money markets are now pricing a June hike of their own as energy-driven inflation in the eurozone pushes headline HICP toward 3%.

In this environment, European private markets — accessed via secondaries at a discount to NAV — still represent a structurally compelling proposition for dollar-based allocators. 

The discount rate is still the master variable — it has just become harder to read

Every private investment remains, at its core, a discounted cash-flow problem. For a project to create value, its expected internal rate of return must exceed the weighted average cost of capital. The cost of equity inside that WACC is built on the Capital Asset Pricing Model: required return equals the risk-free rate plus beta multiplied by the equity risk premium. The risk-free rate is, by convention, the ten-year sovereign yield — Treasuries in the United States, Bunds in the eurozone.

That identity is unchanged. What has changed is the direction of travel. The 2024 consensus — that the Fed would cut aggressively through 2025 and that the ECB would run ahead of it — has been disrupted by a single exogenous shock: the outbreak of the Iran war in late February 2026, which closed the Strait of Hormuz and drove Brent crude above US$105 per barrel. The energy impulse has pushed consumer prices higher on both sides of the Atlantic, forced both central banks to pause, and introduced the genuine possibility that the next move from either institution is a hike rather than a cut.

For private markets practitioners, this means the near-term rate tailwind that many underwriting models assumed through 2025 has stalled. Hurdle rates remain elevated. The universe of transactions that pencil out at prevailing marks has not expanded as quickly as expected. That is the honest framing. The question is what it implies for allocation.

Why venture suffered — and why the recovery thesis survives, on a longer timeline

Venture capital and private equity respond to discount-rate shocks differently because they have very different duration profiles. Leveraged buyouts generate near-term cash flows: operating businesses producing EBITDA within twelve to thirty-six months of close. Venture capital is mathematically a long-duration asset — most of the value sits in terminal exits seven to twelve years out.

When the discount rate rises, the present value of distant cash flows falls disproportionately. A 200 basis-point rise in the risk-free rate barely dents a buyout’s near-term cash flow stream but meaningfully compresses a ten-year venture terminal value. That is the technical reason VC marks fell hardest through 2022–2024 while large-cap buyout marks held up materially better.

The reverse mechanism — that falling rates should benefit VC most — remains structurally valid. It has simply been pushed out. A rate-cutting cycle that markets were pricing as imminent in early 2026 is now, at best, a late-2026 or 2027 story, conditional on the energy shock fading. Allocators who want to position for that recovery need to do so before the cutting cycle is priced back in. The window is available because the consensus has soured. That is historically when vintage-year entry points are most attractive.

The ECB-Fed picture: divergence has given way to symmetry — but the Bund-Treasury spread still matters

The macro divergence narrative between the ECB and the Federal Reserve has narrowed considerably. Both central banks are now balancing persistent inflation pressures against weakening growth expectations.

The ECB held rates unchanged at its April 2026 meeting, explicitly flagging that upside risks to inflation and downside risks to growth had intensified simultaneously — the classic definition of a stagflationary environment. At the time of writing, money markets are pricing an 86% probability of a 25 basis-point ECB hike at the June meeting, with three hikes priced into year-end. The ECB is not behind the Fed; it is facing the same energy-driven dilemma, with its own set of industrial competitiveness pressures layered on top.

What remains true — and matters for the discount-rate arithmetic — is that the absolute level of German Bund yields, even after their recent rise to a 15-year high, sits below equivalent US Treasury yields. The Bund-Treasury spread has compressed but has not closed. European private hurdle rates, built off Bund yields, remain below US hurdle rates for comparable assets. The advantage is smaller than it was in 2024. It has not disappeared.

The nuanced case for Europe in 2026 is not ‘the ECB is dovish.’ It is ‘the base rate differential persists, energy-driven inflation is transitory in the medium-term ECB projection, and European private assets are being marked down at the same time as the macro narrative has deteriorated — creating a vintage-year entry opportunity.’

EUR/USD: the tailwind has become conditional, not directional

EUR/USD is trading around 1.17 at the time of writing, having recovered from its March low of 1.1435 but remaining well below its January 2026 peak of 1.20. The path from here is genuinely two-sided.

The bullish case: an ECB rate hike in June, combined with any softening in US inflation data, narrows the Bund-Treasury spread further and supports the euro toward 1.19–1.20. For a dollar-based allocator deploying capital into euro-denominated assets today, a move back to prior highs represents a currency return of 2–3% on top of the underlying asset IRR.

The bearish case: the US-EU trade dispute, with the Trump administration threatening materially higher tariffs on EU goods unless the bloc removes its own tariffs by 4 July, introduces a genuine euro-negative tail risk. A breakdown in trade talks would weigh on eurozone growth expectations and could pull EUR/USD back toward 1.15 or below.

The honest framing for a USD allocator is that the FX component is no longer a free tailwind — it is a conditional one that needs to be sized honestly in any return scenario analysis. At current levels, the currency is not expensive. The option value of further euro appreciation exists. It should not, however, be the primary thesis.

Low-beta sectors — including utilities, regulated infrastructure, healthcare services and consumer staples — remain structurally attractive in a high-rate and stagflationary environment due to their lower equity risk premium sensitivity within CAPM and the relative resilience of their cash flow profiles.

That thesis is arguably even stronger under current macro conditions, though it requires important nuance. Energy costs are the primary transmission mechanism through which today’s inflation shock affects European industrial and consumer sectors, and defensive assets are not fully insulated from those pressures. Regulated infrastructure and utilities, in particular, face genuine risks from rising operating expenses, margin pressure and the political sensitivity surrounding regulated asset bases in periods of elevated energy costs.

 

What low-beta defensives genuinely offer in this environment is earnings visibility relative to cyclical alternatives. The defensible EBITDA characteristic — the ability to model a range of outcomes with confidence — is worth more when macro uncertainty is high and buyers at exit are applying tighter discount rates. Sectors whose revenues are contractually anchored (regulated infrastructure, government-reimbursed healthcare) continue to price off that characteristic, and do so at a lower beta-implied cost of equity than cyclical sectors.

The necessary caveat on NAV smoothing remains in force. In private markets, part of the apparent low-beta of these sectors reflects appraisal-based quarterly valuation rather than genuine economic diversification. Academic work on private equity returns has consistently shown that the true economic beta of private funds is materially higher than the beta implied by reported NAVs. Allocators should size positions on the basis of economic beta, not reported beta.

In Breslin’s view, the most important implication of the current macro environment is one that actually strengthens, rather than weakens, the secondaries thesis.

Primary fundraising is harder when macro narratives are uncertain. LPs who committed capital to European private equity funds at 2021–2023 valuations, on the assumption of a smooth ECB easing cycle, are now holding positions on a longer-than-expected timeline and at marks that have not recovered to their underwriting cases. That is the supply side of the secondaries market — and it is currently well-stocked.

Secondary buyers, by contrast, are pricing at a known discount to NAV — a NAV that already reflects the rate shock of 2022–2024. They are not paying for a macro scenario that has not yet materialised; they are buying at a price that already embeds meaningful scepticism. In a high-uncertainty environment, that is a structurally attractive entry mechanism.

The four mechanics that favour European private markets for USD allocators in 2026 — lower absolute Bund-based hurdle rates, residual EUR/USD optionality, VC duration convexity on a deferred but intact cutting cycle, and low-beta sector defensiveness in volatile conditions — all remain present. None of them is as clean or as mechanically certain as they appeared three months ago. All of them compound in the direction of Europe when approached through a secondary platform at a discount to NAV.

For the past three decades, Breslin AG has connected sellers of European private equity interests with global buyers. Having transacted more than USD 700 million transacted across over 80 closed deals, anchored in Life Sciences, Energy, Industrials and Non-Cyclicals , our team can support dollar-based allocators with immediate, structured entry into the European private market at a known discount to NAV.

In an environment where the primary macro narrative has become more complicated, but the structural case for European private assets has not reversed, secondaries remain the most price-efficient and risk-controlled way to put that thesis to work.

Discuss a portfolio sale with Breslin

If you hold PE assets and are exploring a secondary sale, the Breslin team will run a confidential assessment – portfolio benchmarking, indicative discount ranges and a recommended process architecture – before any commitment.

 

Get in touch

Private Equity Insights

part-01_forest-night@2x
What Is Corporate Venture Capital? A Short History and How the Market Evolved - THE CORPORATE VENTURE SERIES · PART 1 OF 4
Corporate venture capital explained: what CVC is, how it evolved from the 1960s into a $500bn+ market,...
Read More
06_warm-overcast@2x
European Private Equity Secondaries: Macro Trends, Interest Rates and Investment Opportunities in 2026
Higher US yields, a stronger euro and ECB-Fed divergence are reshaping private equity and venture allocation....
Read More
05_midnight-skyline@2x
Private Equity in DACH Pensions: Caps, Allocators and the Secondary Market
A practical view on how Swiss and German pension funds engage with private equity, the quantitative caps...
Read More
02_facade-daylight@2x
Secondary Market Discounts in DACH: Securing the Best Return on Non-Cyclical, Industrial, Life Science and Energy Portfolios
How DACH sellers of Non-Cyclical, Industrial, Life Science and Energy portfolios can minimise secondary...
Read More
05_midnight-skyline@2x
Secondary Market Opportunities for DACH Insurers
DACH insurers are reviewing private equity holdings in healthcare, life sciences, pharma, agri and technology....
Read More
03_skyline-goldenhour@2x
LP and GP Secondary Market Strategies in 2026: Trends, Pricing and What's Changed​
Private equity secondaries in 2026 are being reshaped by tighter pricing, more sophisticated GP-led deals,...
Read More
04_pale-facade@2x
Private Equity Secondary Market Explained: LP & GP Guide (2026)​
From LP portfolio sales to GP-led continuation vehicles, this article breaks down how the private equity...
Read More
Scroll to Top